Rossari Biotech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 429.05 | 369.28 | 337.07 |
| Operating Expense | 374.45 | 318.32 | 291.72 |
| Net Profit | 32.36 | 30.63 | 27.42 |
| Net Profit Margin | 7.54 | 8.29 | 8.13 |
| Earning Per Share | 5.85 | 5.53 | 4.96 |
| EBIDTA | 55.45 | 51.81 | 45.70 |
| Effective Tax Rate | 22.62 | 22.50 | 21.70 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 429.05 |
| Operating Expense | 374.45 |
| Net Profit | 32.36 |
| Net Profit Margin | 7.54 |
| Earning Per Share | 5.85 |
| EBIDTA | 55.45 |
| Effective Tax Rate | 22.62 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 1,202.91 | 975.17 | 1,072.84 |
| Operating Expenses Annual | 1,041.66 | 852.52 | 950.05 |
| Operating Profit Annual | 168.03 | 126.25 | 135.49 |
| Interest Annual | 9.70 | 4.62 | 2.55 |
| Depreciation | 21.48 | 24.27 | 24.64 |
| Net Profit Annual | 99.65 | 71.39 | 79.47 |
| Tax Annual | 34.49 | 24.26 | 27.21 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 1,202.91 |
| Operating Expenses Annual | 1,041.66 |
| Operating Profit Annual | 168.03 |
| Interest Annual | 9.70 |
| Depreciation | 21.48 |
| Net Profit Annual | 99.65 |
| Tax Annual | 34.49 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 40.50 | 26.74 | 14.83 |
| Cash Flow from Operations | 73.92 | 112.94 | 33.12 |
| Cash Flow from Investing | -69.78 | -160.39 | -318.12 |
| Cash Flow from Financing | -22.09 | 61.21 | 296.91 |
| Cash Flow at the End | 22.55 | 40.50 | 26.74 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 40.50 |
| Cash Flow from Operations | 73.92 |
| Cash Flow from Investing | -69.78 |
| Cash Flow from Financing | -22.09 |
| Cash Flow at the End | 22.55 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 13.97 | 12.95 | 12.63 |
| PBIT Margin (%) | 11.96 | 10.28 | 10.18 |
| PBT Margin (%) | 10.73 | 8.05 | 6.19 |
| Net PROFIT Margin (%) | 8.28 | 7.32 | 7.41 |
| Return On Networth / Equity (%) | 10.96 | 8.69 | 13.37 |
| Return On Networth /Employed (%) | 14.71 | 11.72 | 18.34 |
| Return On Assets (%) | 10.19 | 8.35 | 13.33 |
| Total Debt / Equity (X) | 0.07 | 0.04 | TBA |
| Asset Turnover Ratio (%) | 1.23 | 1.14 | 1.80 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 13.97 |
| PBIT Margin (%) | 11.96 |
| PBT Margin (%) | 10.73 |
| Net PROFIT Margin (%) | 8.28 |
| Return On Networth / Equity (%) | 10.96 |
| Return On Networth /Employed (%) | 14.71 |
| Return On Assets (%) | 10.19 |
| Total Debt / Equity (X) | 0.07 |
| Asset Turnover Ratio (%) | 1.23 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 167.29 | 160.07 | 177.38 |
| Total Current Assets Annual | 566.77 | 469.73 | 368.07 |
| Non Current Assets Annual | 713.19 | 654.73 | 557.86 |
| Total Shareholders Funds Annual | 960.34 | 858.70 | 784.52 |
| Total Assets Annual | 1,281.17 | 1,125.67 | 925.93 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 167.29 |
| Total Current Assets Annual | 566.77 |
| Non Current Assets Annual | 713.19 |
| Total Shareholders Funds Annual | 960.34 |
| Total Assets Annual | 1,281.17 |
EPS (INR)
Expected
6.22
Reported
6.22
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
